Search results
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 6 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 6 days agoModerna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit a new milestone: its first non-Covid product, which...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Digital Journal· 6 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna ...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 6 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
The Cleveland Plain Dealer· 4 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
AOL· 3 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma patients that had received the cancer vaccine combination showed an overall survival rate ...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 6 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 2 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 3 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...